Inactive Instrument
Arix Bioscience plc Share Price
Stocks
ARIX
GB00BD045071
Investment Management & Fund Operators
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Tom Davidson
DFI | Director of Finance/CFO | - | 30/04/2023 |
Laura Craig
IRC | Investor Relations Contact | - | - |
Jade Fletcher
AUD | Comptroller/Controller/Auditor | - | 09/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 28/04/2021 | |
| Director/Board Member | 63 | 09/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/05/23 | Free | Chief Executive Officer | 671,800 | 0.5200% | ||
| 04/05/23 | Sell | Chief Executive Officer | 22,238 | 0.0172% | ||
| 04/05/23 | Sell | Chief Executive Officer | 57,000 | 0.0441% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -1.05% | - | - | 235M | |
| +1.34% | +6.10% | +0.82% | +85.32% | 174B | |
| +1.13% | +0.18% | +31.71% | +86.16% | 145B | |
| +1.28% | +6.12% | +36.50% | +252.04% | 97.07B | |
| -0.46% | +2.84% | -32.34% | +17.78% | 88.26B | |
| +0.51% | +2.88% | -16.92% | +87.41% | 83.41B | |
| +0.38% | +4.23% | -27.86% | +61.54% | 80.08B | |
| -0.33% | +1.26% | -16.02% | +54.51% | 73.41B | |
| +0.97% | +0.50% | +46.67% | +161.06% | 45.45B | |
| +0.55% | -1.36% | +2.03% | +57.08% | 43.08B | |
| Average | +0.48% | +0.42% | +2.73% | +95.88% | 92.26B | |
| Weighted average by Cap. | +0.64% | +1.12% | +3.40% | +95.65% |
Employees
9
